Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Sucralose affects glycemic and hormonal responses to an oral glucose load.
Pepino MY, Tiemann CD, Patterson BW, Wice BM, Klein S. Pepino MY, et al. Among authors: Wice BM. Diabetes Care. 2013 Sep;36(9):2530-5. doi: 10.2337/dc12-2221. Epub 2013 Apr 30. Diabetes Care. 2013. PMID: 23633524 Free PMC article. Clinical Trial.
Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance.
Wang S, Oestricker LZ, Wallendorf MJ, Sterl K, Dunai J, Kilpatrick CR, Patterson BW, Reeds DN, Wice BM. Wang S, et al. Among authors: Wice BM. PLoS One. 2018 Feb 21;13(2):e0192441. doi: 10.1371/journal.pone.0192441. eCollection 2018. PLoS One. 2018. PMID: 29466430 Free PMC article.
Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.
Chowdhury S, Wang S, Dunai J, Kilpatrick R, Oestricker LZ, Wallendorf MJ, Patterson BW, Reeds DN, Wice BM. Chowdhury S, et al. Among authors: Wice BM. PLoS One. 2016 Jun 15;11(6):e0156852. doi: 10.1371/journal.pone.0156852. eCollection 2016. PLoS One. 2016. PMID: 27304975 Free PMC article. Clinical Trial.
Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.
Chowdhury S, Reeds DN, Crimmins DL, Patterson BW, Laciny E, Wang S, Tran HD, Griest TA, Rometo DA, Dunai J, Wallendorf MJ, Ladenson JH, Polonsky KS, Wice BM. Chowdhury S, et al. Among authors: Wice BM. Am J Physiol Gastrointest Liver Physiol. 2014 Feb 15;306(4):G301-9. doi: 10.1152/ajpgi.00383.2013. Epub 2013 Dec 19. Am J Physiol Gastrointest Liver Physiol. 2014. PMID: 24356886 Free PMC article. Clinical Trial.
Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes.
Wice BM, Reeds DN, Tran HD, Crimmins DL, Patterson BW, Dunai J, Wallendorf MJ, Ladenson JH, Villareal DT, Polonsky KS. Wice BM, et al. Diabetes. 2012 Jul;61(7):1793-800. doi: 10.2337/db11-1451. Epub 2012 Apr 20. Diabetes. 2012. PMID: 22522617 Free PMC article. Clinical Trial.
34 results
Jump to page
Feedback